Clinical Trials
12 trialsNCT06645808 2025-12-29
VARTUTRACE
Var2 Pharmaceuticals
Phase EARLY_PHASE1 Recruiting
NCT03433898 2025-12-19
This Study Aims to Find a Safe and Effective Dose of BI 754091. The Study Also Aims to Find Safe and Effective Doses of BI 754091 and BI 754111 in Combination. This Study is Done in Asian Patients With Different Types of Cancer
Boehringer Ingelheim
Phase EARLY_PHASE1 Completed
NCT06635434 2024-10-26
An English/Spanish Mobile Augmented Reality Pain Assessment App for Hispanic/Latino Pediatric Cancer Patients
ALTality, Inc.
Phase EARLY_PHASE1 Active not recruiting
NCT05707325 2024-07-24
Reboot-101
Westlake Therapeutics
Phase EARLY_PHASE1 Recruiting
NCT04509167 2024-03-06
Pilot Study of Neoantigen Peptides for the Treatment of Neoplasms
Instituto de Medicina Regenerativa
Phase EARLY_PHASE1 Completed
NCT05475106 2024-03-06
Pilot Study of Neoantigen Peptides and Leukine for the Treatment of Neoplasms
Instituto de Medicina Regenerativa
Phase EARLY_PHASE1 Recruiting
NCT05104268 2024-02-20
MDOM
E2Bio Life Sciences, LLC
Phase EARLY_PHASE1 Withdrawn
NCT04721756 2022-04-25
Early Clinical Evaluation of 18F-LY3546117 in Tumor Imaging
Avid Radiopharmaceuticals
Phase EARLY_PHASE1 Unknown
NCT04123574 2022-02-24
A Pilot Study of BXCL701 in Patients With Pancreatic Cancer
BioXcel Therapeutics Inc
Phase EARLY_PHASE1 Withdrawn
NCT04702841 2021-03-08
CAR - γ δ T Cells in the Treatment of Relapsed and Refractory CD7 Positive T Cell-derived Malignant Tumors
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Phase EARLY_PHASE1 Unknown
NCT04691349 2021-01-11
CAR-T for r/r Malignant Tumors in Children
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Phase EARLY_PHASE1 Unknown
NCT01678690 2016-09-02
An Exploratory Study of Gemcitabine Hydrochloride Oral Formulation (D07001-F4) in Subjects With Malignant Tumors
InnoPharmax Inc.
Phase EARLY_PHASE1 Completed